Lebenthal Global Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$894K Buy
4,182
+2,317
+124% +$518K 0.13% 121
2025
Q4
$319K Buy
+1,865
New +$290K 0.05% 168
2023
Q1
Sell
-5,680
Closed -$239K 125
2022
Q4
$239K Buy
5,680
+160
+3% +$6.69K 0.08% 119
2022
Q3
$202K Sell
5,520
-150
-3% -$6.68K 0.09% 110
2022
Q2
$241K Buy
5,670
+70
+1% +$3.33K 0.12% 115
2022
Q1
$301K Sell
5,600
-730
-12% -$42.5K 0.13% 115
2021
Q4
$455K Buy
+6,330
New +$397K 0.18% 87
2021
Q1
Sell
-2,860
Closed -$135K 363
2020
Q4
$135K Buy
+2,860
New +$120K 0.1% 133

Other funds holding LRCX

Lebenthal Global Advisors's LRCX Position: Q1 2026 in Review

Lebenthal Global Advisors increased its Lam Research (LRCX) stake by 124% in Q1 2026, buying an estimated $518K and bringing the position to 4,182 shares worth $894K. The position accounts for 0.13% of the portfolio, ranked #121.

Lebenthal Global Advisors first reported a position in LRCX in Q4 2020 and has held it in 8 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Lebenthal Global Advisors held 4,182 shares of Lam Research worth $894K as of Q1 2026.
  • Lebenthal Global Advisors bought 2,317 Lam Research shares in Q1 2026, an estimated $518K.
  • Lam Research made up 0.13% of Lebenthal Global Advisors's portfolio in Q1 2026, its #121 holding.
  • Lebenthal Global Advisors first reported a position in Lam Research in Q4 2020 and has held it in 8 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.